Riik: Suurbritannia
keel: inglise
Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nicorandil
Zentiva Pharma UK Ltd
C01DX16
Nicorandil
20mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060300; GTIN: 5000283651758
140 mm 540 mm Package leaflet: information for the user Nicorandil 10 mg and 20 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or pharmacist. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What in this leaflet 1. What Nicorandil is and what it is used for 2. What you need to know before you take Nicorandil 3. How to take Nicorandil 4. Possible side effects 5. How to store Nicorandil 6. Contents of the pack and other information 1. What Nicorandil is and what it is used for The name of your medicine is Nicorandil 10 mg or 20 mg Tablets (called Nicorandil in this leaflet). The active ingredient in this medicine is called Nicorandil. This belongs to a group of medicines called ‘potassium channel activators’. Nicorandil is used to prevent or reduce painful signs (angina pectoris) of your heart disease. It is used in adults who cannot take heart medicines called beta-blockers and/or calcium antagonists. This medicine works by increasing the blood flow through the blood vessels of the heart. It improves the blood and oxygen supply to your heart muscle and reduces its workload. 2. What you need to know before you take Nicorandil Do not take Nicorandil if you: • are allergic to nicorandil or any of the other ingredients of this medicine (listed in section 6). • have low blood pressure (hypotension). • have heart problems such as cardiogenic shock, or left ventricular failure with low filling pressure or heart decompensation or shock. • are taking medicines to treat erectile dysfunction such as sildenafil, tadalfil, vardenafil (phosphodiesterase inhibitors) or medic Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nicorandil 20 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 mg of Nicorandil. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. White to off white coloured, round, flat bevelled edge, uncoated tablet debossed with ‘ND 20’ on one side and break line on other side. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nicorandil is indicated in adults for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or have a contraindication or intolerance to first-line antianginal therapies (such as beta- blockers and/or calcium antagonists). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The usual therapeutic range is 10 to 20 mg twice daily. The usual starting dose is 10 mg twice daily (bid), in the morning and in the evening preferably. It is recommended that the dose be titrated upwards in accordance with the patient’s needs, response and tolerance up to 40 mg twice daily, if necessary. A lower starting dose of 5 mg twice daily may be used in patients particularly prone to headache. Elderly There are no special dose requirements for elderly patients, but as with all medicines, use of the lowest effective dose is recommended. _Patients with liver and/or renal impairment _ There are no special dosage requirements for patients with liver and/or renal impairment. _Paediatric population _ Nicorandil is not recommended in paediatric patients since its safety and efficacy have not been established in this patient group. Method of administration Nicorandil is administered by oral route. The tablets are to be swallowed in the morning and in the evening as a whole with some liquid. Administration is independent of food intake. 4.3 CONTRAINDICATIONS • Hypersensitivity to nicorandil or to any of the excipients listed in section 6.1. • Patients with shock (including cardiogenic shock), severe hypotension, or Lugege kogu dokumenti